Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.
Ostuni
P
P
Botsios
C
C
Punzi
L
L
Sfriso
P
P
Todesco
S
S
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006515:Hepatitis B virus / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D014775:Virus Activation
D000911:Antibodies, Monoclonal; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D000069285:Infliximab; D008727:Methotrexate